Microfabricated physiological models for in vitro drug screening applications

Micromachines

Volumn 7, Issue 12, 2016, Pages

  Ugolini, Giovanni Stefano ^a   Cruz Moreira, Daniela ^a   Visone, Roberta ^a   Redaelli, Alberto ^a   Rasponi, Marco ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

Drug screening; Microfluidics; Organ on chips; Physiological models

Indexed keywords

CELL CULTURE; MICROFABRICATION; MICROFLUIDICS; PHYSIOLOGY;

BIOLOGICAL MODELS; CULTURE CONDITIONS; DRUG SCREENING; EXTRACELLULAR MATRICES; MICRO-FLUIDIC DEVICES; MICROFABRICATED DEVICES; ON CHIPS; PHYSIOLOGICAL CONDITION;

PHYSIOLOGICAL MODELS;

EID: 85007357011     PISSN: None     EISSN: 2072666X     Source Type: Journal    
DOI: 10.3390/mi7120233     Document Type: Review

References (186)

1. DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. The price of innovation: New estimates of drug development costs. J. Health Econ. 2003, 22, 151-185
2. DiMasi, J.A.; Grabowski, H.G.; Hansen, R.W. Innovation in the pharmaceutical industry: New estimates of R&D costs. J. Health Econ. 2016, 47, 20-33
3. Lipsky, M.S.; Sharp, L.K. From idea to market: The drug approval process FDA: A historical perspective. Development 2001, 14, 362-367
4. Costa, A.; Sarmento, B.; Seabra, V. An evaluation of the latest in vitro tools for drug metabolism studies. Expert Opin. Drug Metab. Toxicol 2014, 10, 103-119
5. Wienkers, L.C.; Heath, T.G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discov. 2005, 4, 825-833
6. Cook, N.; Jodrell, D.I.; Tuveson, D.A. Predictive in vivo animal models and translation to clinical trials. Drug Discov. Today 2012, 17, 253-260
7. Pammolli, F.; Magazzini, L.; Riccaboni, M. The productivity crisis in pharmaceutical R&D. Nat. Rev. Drug Discov. 2011, 10, 428-438
8. Kola, I.; Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2004, 3, 1-5
9. DiMasi, J.A.; Grabowski, H.G.; Hansen, R.W. The cost of drug development. N. Engl. J. Med. 2015, 372, 1972
10. Mak, I.W.; Evaniew, N.; Ghert, M. Lost in translation: Animal models and clinical trials in cancer treatment. Am. J. Transl. Res. 2014, 6, 114-118
11. Schuh, J.C.L. Trials, tribulations, and trends in tumor modeling in mice. Toxicol. Pathol. 2004, 32 (Suppl. 1), 53-66
12. Seok, J.; Warren, H.S.; Cuenca, A.G.; Mindrinos, M.N.; Baker, H.V.; Xu, W.; Richards, D.R.; McDonald-Smith, G.P.; Gao, H.; Hennessy, L.; et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2013, 110, 3507-3512
13. Whitesides, G.M. The origins and the future of microfluidics. Nature 2006, 442, 368-373
14. Sackmann, E.K.; Fulton, A.L.; Beebe, D.J. The present and future role of microfluidics in biomedical research. Nature 2014, 507, 181-189
15. Huh, D.; Hamilton, G.A.; Ingber, D.E. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011, 21, 745-754
16. Huh, D.; Torisawa, Y.; Hamilton, G.A.; Kim, H.J.; Ingber, D.E. Microengineered physiological biomimicry: Organs-on-Chips. Lab Chip 2012, 12, 2156-2164
17. Bhatia, S.N.; Ingber, D.E. Microfluidic organs-on-chips. Nat. Biotechnol. 2014, 32, 760-772
18. Yum, K.; Hong, S.G.; Healy, K.E.; Lee, L.P. Physiologically relevant organs on chips. Biotechnol. J. 2014, 9, 16-27
19. Zheng, F.; Fu, F.; Cheng, Y.; Wang, C.; Zhao, Y.; Gu, Z. Organ-on-a-Chip Systems: Microengineering to biomimic living systems. Small 2016, 12, 2253-2282
20. Perestrelo, A.R.; Águas, A.C.P.; Rainer, A.; Forte, G. Microfluidic organ/body-on-a-chip devices at the convergence of biology and microengineering. Sensors 2015, 15, 29848
21. Li, A.P.; Lu, C.; Brent, J.A.; Pham, C.; Fackett, A.; Ruegg, C.E.; Silber, P.M. Cryopreserved human hepatocytes: Characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact. 1999, 121, 17-35
22. Wrighton, S.A.; Stevens, J.C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 1992, 22, 1-21
23. Gerets, H.H.J.; Tilmant, K.; Gerin, B.; Chanteux, H.; Depelchin, B.O.; Dhalluin, S.; Atienzar, F.A. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol. Toxicol. 2012, 28, 69-87
24. Ravi, M.; Paramesh, V.; Kaviya, S.R.; Anuradha, E.; Paul Solomon, F.D. 3D cell culture systems: Advantages and applications. J. Cell. Physiol. 2015, 230, 16-26
25. Tibbitt, M.W.; Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng. 2009, 103, 655-663
26. Van Duinen, V.; Trietsch, S.J.; Joore, J.; Vulto, P.; Hankemeier, T. Microfluidic 3D cell culture: From tools to tissue models. Curr. Opin. Biotechnol. 2015, 35, 118-126
27. Huang, G.Y.; Zhou, L.H.; Zhang, Q.C.; Chen, Y.M.; Sun, W.; Xu, F.; Lu, T.J. Microfluidic hydrogels for tissue engineering. Biofabrication 2011, 3, 12001
28. Toh, Y.-C.; Zhang, C.; Zhang, J.; Khong, Y.M.; Chang, S.; Samper, V.D.; van Noort, D.; Hutmacher, D.W.; Yu, H. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 2007, 7, 302-309
29. Au, S.H.; Chamberlain, M.D.; Mahesh, S.; Sefton, M.V.; Wheeler, A.R. Hepatic organoids for microfluidic drug screening. Lab Chip 2014, 14, 3290-3299
30. Zhang, C.; Chia, S.M.; Ong, S.M.; Zhang, S.; Toh, Y.C.; van Noort, D.; Yu, H. The controlled presentation of TGF-beta1 to hepatocytes in a 3D-microfluidic cell culture system. Biomaterials 2009, 30, 3847-3853
31. Toh, Y.-C.; Lim, T.C.; Tai, D.; Xiao, G.; van Noort, D.; Yu, H. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009, 9, 2026-2035
32. Kim, M.S.; Yeon, J.H.; Park, J.-K. A microfluidic platform for 3-dimensional cell culture and cell-based assays. Biomed. Microdevices 2007, 9, 25-34
33. Bhise, N.S.; Manoharan, V.; Massa, S.; Tamayol, A.; Ghaderi, M.; Miscuglio, M.; Lang, Q.; Zhang, Y.S.; Shin, S.R.; Calzone, G.; et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication 2016, 8, 14101
34. Dash, A.; Inman, W.; Hoffmaster, K.; Sevidal, S.; Kelly, J.; Obach, R.S.; Griffith, L.G.; Tannenbaum, S.R. Liver tissue engineering in the evaluation of drug safety. Expert Opin. Drug Metab. Toxicol. 2009, 5, 1159-1174
35. Soldatow, V.Y.; LeCluyse, E.L.; Griffith, L.G.; Rusyn, I. In vitro models for liver toxicity testing. Toxicol. Res. (Camb.) 2013, 2, 23-39
36. Kang, Y.B.A.; Rawat, S.; Cirillo, J.; Bouchard, M.; Noh, H.M. Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: Toward engineering the liver sinusoid. Biofabrication 2013, 5, 45008
37. Ohno, M.; Motojima, K.; Okano, T.; Taniguchi, A. Up-regulation of drug-metabolizing enzyme genes in layered co-culture of a human liver cell line and endothelial cells. Tissue Eng. Part A 2008, 14, 1861-1869
38. Bhushan, A.; Senutovitch, N.; Bale, S.S.; McCarty, W.J.; Hegde, M.; Jindal, R.; Golberg, I.; Berk Usta, O.; Yarmush, M.L.; Vernetti, L.; et al. Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans. Stem Cell Res. Ther. 2013, 4 (Suppl. 1), S16
39. Zhou, Q.; Patel, D.; Kwa, T.; Haque, A.; Matharu, Z.; Stybayeva, G.; Gao, Y.; Diehl, A.M.; Revzin, A. Liver injury-on-a-chip: Microfluidic co-cultures with integrated biosensors for monitoring liver cell signaling during injury. Lab Chip 2015, 15, 4467-4478
40. Rennert, K.; Steinborn, S.; Gröger, M.; Ungerböck, B.; Jank, A.M.; Ehgartner, J.; Nietzsche, S.; Dinger, J.; Kiehntopf, M.; Funke, H.; et al. A microfluidically perfused three dimensional human liver model. Biomaterials 2015, 71, 119-131
41. Khetani, S.R.; Bhatia, S.N. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 2008, 26, 120-126
42. Ma, C.; Zhao, L.; Zhou, E.M.; Xu, J.; Shen, S.; Wang, J. On-chip construction of liver lobule-like microtissue and its application for adverse drug reaction assay. Anal. Chem. 2016, 88, 1719-1727
43. Prot, J.M.; Aninat, C.; Griscom, L.; Razan, F.; Brochot, C.; Guillouzo, C.G.; Legallais, C.; Corlu, A.; Leclerc, E. Improvement of HepG2/C3a cell functions in a microfluidic biochip. Biotechnol. Bioeng. 2011, 108, 1704-1715
44. Baudoin, R.; Legendre, A.; Jacques, S.; Cotton, J.; Bois, F.; Leclerc, E. Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats. J. Pharm. Sci. 2014, 103, 706-718
45. Prot, J.M.; Briffaut, A.S.; Letourneur, F.; Chafey, P.; Merlier, F.; Grandvalet, Y.; Legallais, C.; Leclerc, E. Integrated proteomic and transcriptomic investigation of the acetaminophen toxicity in liver microfluidic biochip. PLoS ONE 2011, 6, e21268
46. Prot, J.M.; Videau, O.; Brochot, C.; Legallais, C.; Bénech, H.; Leclerc, E. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. Int. J. Pharm. 2011, 408, 67-75
47. Baudoin, R.; Griscom, L.; Prot, J.M.; Legallais, C.; Leclerc, E. Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor. Biochem. Eng. J. 2011, 53, 172-181
48. Lee, P.J.; Hung, P.J.; Lee, L.P. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol. Bioeng. 2007, 97, 1340-1346
49. Esch, M.B.; Prot, J.-M.; Wang, Y.I.; Miller, P.; Llamas-Vidales, J.R.; Naughton, B.A.; Applegate, D.R.; Shuler, M.L.; Facility, C.N. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip 2015, 15, 2269-2277
50. Carraro, A.; Hsu, W.M.; Kulig, K.M.; Cheung, W.S.; Miller, M.L.; Weinberg, E.J.; Swart, E.F.; Kaazempur-Mofrad, M.; Borenstein, J.T.; Vacanti, J.P.; et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed. Microdevices 2008, 10, 795-805
51. Novik, E.; Maguire, T.J.; Chao, P.; Cheng, K.C.; Yarmush, M.L. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem. Pharmacol. 2010, 79, 1036-1044
52. Kim, Y.; Lobatto, M.E.; Kawahara, T.; Lee Chung, B.; Mieszawska, A.J.; Sanchez-Gaytan, B.L.; Fay, F.; Senders, M.L.; Calcagno, C.; Becraft, J.; et al. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proc. Natl. Acad. Sci. USA 2014, 111, 1078-1083
53. DiNunzio, J.C.; Williams, R.O. CNS disorders-current treatment options and the prospects for advanced therapies. Drug Dev. Ind. Pharm. 2008, 34, 1141-1167
54. Chung, B.G.; Flanagan, L.A.; Rhee, S.W.; Schwartz, P.H.; Lee, A.P.; Monuki, E.S.; Jeon, N.L. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip 2005, 5, 401-406
55. Kapur, T.A.; Shoichet, M.S. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. J. Biomed. Mater. Res. A 2004, 68, 235-243
56. Romano, N.H.; Lampe, K.J.; Xu, H.; Ferreira, M.M.; Heilshorn, S.C. Microfluidic gradients reveal enhanced neurite outgrowth but impaired guidance within 3D matrices with high integrin ligand densities. Small 2015, 11, 722-730
57. Kunze, A.; Meissner, R.; Brando, S.; Renaud, P. Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies. Biotechnol. Bioeng. 2011, 108, 2241-2245
58. Xiao, R.R.; Zeng, W.J.; Li, Y.T.; Zou, W.; Wang, L.; Pei, X.F.; Xie, M.; Huang, W.H. Simultaneous generation of gradients with gradually changed slope in a microfluidic device for quantifying axon response. Anal. Chem. 2013, 85, 7842-7850
59. Joanne, W.C.; Li, X.; Lin, B.; Shim, S.; Ming, G.-L.; Levchenko, A. A microfluidics-based turning assay reveals complex growth cone responses to integrated gradients of substrate-bound ECM molecules and diffusible guidance cues. Lab Chip 2008, 8, 227-237
60. Huang, H.; Jiang, L.; Li, S.; Deng, J.; Li, Y.; Yao, J.; Li, B.; Zheng, J. Using microfluidic chip to form brain-derived neurotrophic factor concentration gradient for studying neuron axon guidance. Biomicrofluidics 2014, 8, 014108
61. Taylor, A.M.; Menon, S.; Gupton, S.L. Passive microfluidic chamber for long-term imaging of axon guidance in response to soluble gradients. Lab Chip 2015, 15, 2781-2789
62. Kothapalli, C.R.; van Veen, E.; de Valence, S.; Chung, S.; Zervantonakis, I.K.; Gertler, F.B.; Kamm, R.D. A high-throughput microfluidic assay to study neurite response to growth factor gradients. Lab Chip 2011, 11, 497-507
63. Taylor, A.M.; Blurton-Jones, M.; Rhee, S.W.; Cribbs, D.H.; Cotman, C.W.; Jeon, N.L. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods 2005, 2, 599-605
64. Taylor, A.M.; Dieterich, D.C.; Ito, H.T.; Kim, S.A.; Schuman, E.M. Microfluidic local perfusion chambers for the visualization and manipulation of synapses. Neuron 2010, 66, 57-68
65. Hellman, A.N.; Vahidi, B.; Kim, H.J.; Mismar, W.; Steward, O.; Jeon, N.L.; Venugopalan, V. Examination of axonal injury and regeneration in micropatterned neuronal culture using pulsed laser microbeam dissection. Lab Chip 2010, 10, 2083-2092
66. Park, J.W.; Vahidi, B.; Kim, H.J.; Rhee, S.W.; Jeon, N.L. Quantitative analysis of CNS axon regeneration using a microfluidic neuron culture device. Biochip J. 2008, 2, 44-51
67. Gao, Y.; Broussard, J.; Haque, A.; Revzin, A.; Lin, T. Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device. Microsyst. Nanoeng. 2016, 2, 15045
68. Johnstone, A.F.M.; Gross, G.W.; Weiss, D.G.; Schroeder, O.H.U.; Gramowski, A.; Shafer, T.J. Microelectrode arrays: A physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology 2010, 31, 331-350
69. Dworak, B.J.; Wheeler, B.C. Novel MEA platform with PDMS microtunnels enables the detection of action potential propagation from isolated axons in culture. Lab Chip 2009, 9, 404-410
70. Ravula, S.K.; Wang, M.S.; McClain, M.A.; Asress, S.A.; Frazier, B.; Glass, J.D. Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration. Neurosci. Lett. 2007, 415, 34-39
71. Biffi, E.; Piraino, F.; Pedrocchi, A.; Fiore, G.B.; Ferrigno, G.; Redaelli, A.; Menegon, A.; Rasponi, M. A microfluidic platform for controlled biochemical stimulation of twin neuronal networks. Biomicrofluidics 2012, 6
72. Biffi, E.; Menegon, A.; Piraino, F.; Pedrocchi, A.; Fiore, G.B.; Rasponi, M. Validation of long-term primary neuronal cultures and network activity through the integration of reversibly bonded microbioreactors and MEA substrates. Biotechnol. Bioeng. 2012, 109, 166-175
73. Scott, A.; Weir, K.; Easton, C.; Huynh, W.; Moody, W.J.; Folch, A. A microfluidic microelectrode array for simultaneous electrophysiology, chemical stimulation, and imaging of brain slices. Lab Chip 2013, 13, 527-535
74. Pardridge, W.M. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metab. 2012, 32, 1959-1972
75. Pardridge, W.M. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2005, 2, 3-14
76. Lockman, P.R.; Mumper, R.J.; Khan, M.A.; Allen, D.D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 2002, 28, 1-13
77. Griep, L.M.; Wolbers, F.; de Wagenaar, B.; Ter Braak, P.M.; Weksler, B.B.; Romero, I.A.; Couraud, P.O.; Vermes, I.; van der Meer, A.D.; van den Berg, A. BBB on CHIP: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices 2013, 15, 145-150
78. Prabhakarpandian, B.; Shen, M.-C.; Nichols, J.B.; Mills, I.R.; Sidoryk-Wegrzynowicz, M.; Aschner, M.; Pant, K. SyM-BBB: A microfluidic blood brain barrier model. Lab Chip 2013, 13, 1093-1101
79. Achyuta, A.K.H.; Conway, A.J.; Crouse, R.B.; Bannister, E.C.; Lee, R.N.; Katnik, C.P.; Behensky, A.A.; Cuevas, J.; Sundaram, S.S. A modular approach to create a neurovascular unit-on-a-chip. Lab Chip 2013, 542-553
80. Booth, R.; Kim, H. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip 2012, 12, 1784-1792
81. Brown, J.A.; Pensabene, V.; Markov, D.A.; Allwardt, V.; Diana Neely, M.; Shi, M.; Britt, C.M.; Hoilett, O.S.; Yang, Q.; Brewer, B.M.; et al. Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. Biomicrofluidics 2015, 9, 054124
82. Herland, A.; van der Meer, A.D.; FitzGerald, E.A.; Park, T.E.; Sleeboom, J.J.F.; Ingber, D.E. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip. PLoS ONE 2016, 11, e0150360
83. Wang, J.D.; Khafagy, E.S.; Khanafer, K.; Takayama, S.; Elsayed, M.E.H. Organization of endothelial cells, pericytes, and astrocytes into a 3D microfluidic in vitro model of the blood-brain barrier. Mol. Pharm. 2016, 13, 895-906
84. Cho, H.; Seo, J.H.; Wong, K.H.K.; Terasaki, Y.; Park, J.; Bong, K.; Arai, K.; Lo, E.H.; Irimia, D. Three-dimensional blood-brain barrier model for in vitro studies of neurovascular pathology. Sci. Rep. 2015, 5, 15222
85. Liang, P.; Lan, F.; Lee, A.S.; Gong, T.; Sanchez-Freire, V.; Wang, Y.; Diecke, S.; Sallam, K.; Knowles, J.W.; Wang, P.J.; et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 2013, 127, 1677-1691
86. Ugolini, G.S.; Rasponi, M.; Pavesi, A.; Santoro, R.; Kamm, R.; Fiore, G.B.; Pesce, M.; Soncini, M. On-chip assessment of human primary cardiac fibroblasts proliferative responses to uniaxial cyclic mechanical strain. Biotechnol. Bioeng. 2016, 113, 859-869
87. Marsano, A.; Conficconi, C.; Lemme, M.; Occhetta, P.; Gaudiello, E.; Votta, E.; Cerino, G.; Redaelli, A.; Rasponi, M. Beating heart on a chip: A novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip 2015, 16, 599-610
88. Pavesi, A.; Adriani, G.; Rasponi, M.; Zervantonakis, I.; Fiore, G.; Kamm, R. Controlled electromechanical cell stimulation on-a-chip. Sci. Rep. 2015, 5, 11800
89. Abassi, Y.A.; Xi, B.; Li, N.; Ouyang, W.; Seiler, A.; Watzele, M.; Kettenhofen, R.; Bohlen, H.; Ehlich, A.; Kolossov, E.; et al. Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br. J. Pharmacol. 2012, 165, 1424-1441
90. Xi, B.; Wang, T.; Li, N.; Ouyang, W.; Zhang, W.; Wu, J.; Xu, X.; Wang, X.; Abassi, Y.A. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System. J. Lab. Autom. 2011, 16, 415-421
91. Hu, N.; Wang, T.; Wang, Q.; Zhou, J.; Zou, L.; Su, K.; Wu, J.; Wang, P. High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition. Biosens. Bioelectron. 2015, 67, 146-153
92. Wang, T.; Hu, N.; Cao, J.; Wu, J.; Su, K.; Wang, P. A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating. Biosens. Bioelectron. 2013, 49, 9-13
93. Werdich, A.A.; Lima, E.A.; Ivanov, B.; Ges, I.; Anderson, M.E.; Wikswo, J.P.; Baudenbacher, F.J. A microfluidic device to confine a single cardiac myocyte in a sub-nanoliter volume on planar microelectrodes for extracellular potential recordings. Lab Chip 2004, 4, 357-362
94. Ganitkevich, V.; Reil, S.; Schwethelm, B.; Schroeter, T.; Benndorf, K. Dynamic responses of single cardiomyocytes to graded ischemia studied by oxygen clamp in on-chip picochambers. Circ. Res. 2006, 99, 165-171
95. Cheng, W.; Klauke, N.; Smith, G.; Cooper, J.M. Microfluidic cell arrays for metabolic monitoring of stimulated cardiomyocytes. Electrophoresis 2010, 31, 1405-1413
96. Grosberg, A.; Alford, P.W.; McCain, M.L.; Parker, K.K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip. Lab Chip 2011, 11, 4165-4173
97. Heidi Au, H.T.; Cui, B.; Chu, Z.E.; Veres, T.; Radisic, M. Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip 2009, 9, 564-575
98. Agarwal, A.; Goss, J.A.; Cho, A.; McCain, M.L.; Parker, K.K. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 2013, 13, 3599-3608
99. Wang, G.; McCain, M.L.; Yang, L.; He, A.; Pasqualini, F.S.; Agarwal, A.; Yuan, H.; Jiang, D.; Zhang, D.; Zangi, L.; et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 2014, 20, 616-623
100. Nunes, S.S.; Miklas, J.W.; Liu, J.; Aschar-Sobbi, R.; Xiao, Y.; Zhang, B.; Jiang, J.; Massé, S.; Gagliardi, M.; Hsieh, A.; et al. Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10, 781-787
101. Sun, X.; Nunes, S.S. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Methods 2016, 101, 21-26
102. Xiao, Y.; Zhang, B.; Liu, H.; Miklas, J.W.; Gagliardi, M.; Pahnke, A.; Thavandiran, N.; Sun, Y.; Simmons, C.; Keller, G.; et al. Microfabricated perfusable cardiac biowire: A platform that mimics native cardiac bundle. Lab Chip 2014, 14, 869-882
103. Mathur, A.; Loskill, P.; Shao, K.; Huebsch, N.; Hong, S.; Marcus, S.G.; Marks, N.; Mandegar, M.; Conklin, B.R.; Lee, L.P.; et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 2015, 5, 8883
104. Li, M.; Hotaling, N.A.; Ku, D.N.; Forest, C.R. Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses. PLoS ONE 2014, 9, e82493
105. Li, M.; Ku, D.N.; Forest, C.R. Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood. Lab Chip 2012, 12, 1355-1362
106. Dimasi, A.; Rasponi, M.; Sheriff, J.; Chiu, W.C.; Bluestein, D.; Tran, P.L.; Slepian, M.J.; Redaelli, A. Microfluidic emulation of mechanical circulatory support device shear-mediated platelet activation. Biomed. Microdevices 2015, 17, 1-11
107. Korin, N.; Kanapathipillai, M.; Matthews, B.D.; Crescente, M.; Brill, A.; Mammoto, T.; Ghosh, K.; Jurek, S.; Bencherif, S.A.; Bhatta, D.; et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 2012, 337, 738-742
108. Chrobak, K.M.; Potter, D.R.; Tien, J. Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 2006, 71, 185-196
109. Lee, H.; Kim, S.; Chung, M.; Kim, J.H.; Jeon, N.L. A bioengineered array of 3D microvessels for vascular permeability assay. Microvasc. Res. 2014, 91, 90-98
110. Sato, M.; Sasaki, N.; Ato, M.; Hirakawa, S.; Sato, K.; Sato, K. Microcirculation-on-a-chip: A microfluidic platform for assaying blood-and lymphatic-vessel permeability. PLoS ONE 2015, 10, e0137301
111. Günther, A.; Yasotharan, S.; Vagaon, A.; Lochovsky, C.; Pinto, S.; Yang, J.; Lau, C.; Voigtlaender-Bolz, J.; Bolz, S.-S. A microfluidic platform for probing small artery structure and function. Lab Chip 2010, 10, 2341-2349
112. Yasotharan, S.; Pinto, S.; Sled, J.G.; Bolz, S.-S.; Günther, A. Artery-on-a-chip platform for automated, multimodal assessment of cerebral blood vessel structure and function. Lab Chip 2015, 15, 2660-2669
113. Wagner, W.R.; Griffith, B.P. Reconstructing the lung. Science 2010, 329, 520-522
114. Hittinger, M.; Juntke, J.; Kletting, S.; Schneider-Daum, N.; de Souza Carvalho, C.; Lehr, C.-M. Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models. Adv. Drug Deliv. Rev. 2015, 85, 44-56
115. Fernandes, C.A.; Vanbever, R. Preclinical models for pulmonary drug delivery. Expert Opin. Drug Deliv. 2009, 6, 1231-1245
116. Hakkinen, K.M.; Harunaga, J.S.; Doyle, A.D.; Yamada, K.M. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng. Part A 2011, 17, 713-724
117. Capulli, A.K.; Tian, K.; Mehandru, N.; Bukhta, A.; Choudhury, S.F.; Suchyta, M.; Parker, K.K. Approaching the in vitro clinical trial: Engineering organs on chips. Lab Chip 2014, 14, 3181-3186
118. Zosky, G.R.; Sly, P.D. Animal models of asthma. Clin. Exp. Allergy 2007, 37, 973-988
119. Van der Worp, H.B.; Howells, D.W.; Sena, E.S.; Porritt, M.J.; Rewell, S.; O'Collins, V.; Macleod, M.R. Can animal models of disease reliably inform human studies? PLoS Med. 2010, 7, 1-8
120. Nichols, J.E.; Niles, J.A.; Vega, S.P.; Argueta, L.B.; Eastaway, A.; Cortiella, J. Modeling the lung: Design and development of tissue engineered macro-and micro-physiologic lung models for research use. Exp. Biol. Med. 2014, 239, 1135-1169
121. Dongeun, H.; Benjamin, D.M.; Akiko, M.; Martín, M.-Z.; Hong, Y.H.; Donald, E.I. Reconstituting organ level lung functions on a chip. Science 2010, 328, 1662-1668
122. Huh, D.; Leslie, D.C.; Matthews, B.D.; Fraser, J.P.; Jurek, S.; Hamilton, G.A.; Thorneloe, K.S.; McAlexander, M.A.; Ingber, D.E. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 2012, 4, 159ra147
123. Huh, D. A human breathing lung-on-a-chip. Ann. Am. Thorac. Soc. 2015, 12, S42-S44
124. Benam, K.H.; Villenave, R.; Lucchesi, C.; Varone, A.; Hubeau, C.; Lee, H.-H.; Alves, S.E.; Salmon, M.; Ferrante, T.C.; Weaver, J.C.; et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 2016, 13, 151-157
125. Kudlacz, E.; Conklyn, M.; Andresen, C.; Whitney-Pickett, C.; Changelian, P. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. Eur. J. Pharmacol. 2008, 582, 154-161
126. Nesmith, A.P.; Agarwal, A.; McCain, M.L.; Parker, K.K. Human airway musculature on a chip: An in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. Lab Chip 2014, 14, 3925-3936
127. Chetta, A.; Foresi, A.; del Donno, M.; Bertorelli, G.; Pesci, A.; Olivieri, D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997, 111, 852-857
128. Fernandes, L.B.; Fryer, A.D.; Hirshman, C.A. M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J. Pharmacol. Exp. Ther. 1992, 262, 119-126
129. Stucki, A.O.; Stucki, J.D.; Hall, S.R.R.; Felder, M.; Mermoud, Y.; Schmid, R.A.; Geiser, T.; Guenat, O.T. A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. Lab Chip 2015, 15, 1302-1310
130. Wang, S.; Yue, F.; Zhang, L.; Wang, J.; Wang, Y.; Li, J.; Lin, B.; Qi, W. Application of microfluidic gradient chip in the analysis of lung cancer chemotherapy resistance. J. Pharm. Biomed. Anal. 2009, 49, 806-810
131. Ying, L.; Zhu, Z.; Xu, Z.; He, T.; Li, E.; Guo, Z.; Liu, F.; Jiang, C.; Wang, Q. Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung cancer A549 cells by up-regulating the PI3K/Akt and GRP78 signaling on a microfluidic platform. PLoS ONE 2015, 10, 1-15
132. Hirschhaeuser, F.; Menne, H.; Dittfeld, C.; West, J.; Mueller-Klieser, W.; Kunz-Schughart, L.A. Multicellular tumor spheroids: An underestimated tool is catching up again. J. Biotechnol. 2010, 148, 3-15
133. Barbone, D.; Yang, T.M.; Morgan, J.R.; Gaudino, G.; Broaddus, V.C. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J. Biol. Chem. 2008, 283, 13021-13030
134. Wang, L.; Liu, W.; Wang, Y.; Wang, J.; Tu, Q.; Liu, R.; Wang, J. Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment. Lab Chip 2013, 13, 695-705
135. Ruppen, J.; Cortes-Dericks, L.; Marconi, E.; Karoubi, G.; Schmid, R.A.; Peng, R.; Marti, T.M.; Guenat, O.T. A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids. Lab Chip 2014, 14, 1198-1205
136. Xu, Z.; Gao, Y.; Hao, Y.; Li, E.; Wang, Y.; Zhang, J.; Wang, W.; Gao, Z.; Wang, Q. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 2013, 34, 4109-4117
137. Jang, K.-J.; Suh, K.-Y. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 2010, 10, 36-42
138. Pallone, T.L.; Silldorff, E.P.; Turner, M.R. Intrarenal blood flow: Microvascular anatomy and the regulation of medullary perfusion. Clin. Exp. Pharmacol. Physiol. 1998, 25, 383-392
139. Tiong, H.Y.; Huang, P.; Xiong, S.; Li, Y.; Vathsala, A.; Zink, D. Drug-induced nephrotoxicity: Clinical impact and preclinical in vitro models. Mol. Pharm. 2014, 11, 1933-1948
140. Naughton, C.A. Drug-induced nephrotoxicity. Am. Fam. Phys. 2008, 78, 743-750
141. Perazella, M.A. Renal vulnerability to drug toxicity. Clin. J. Am. Soc. Nephrol. 2009, 4, 1275-1283
142. Schetz, M.; Dasta, J.; Goldstein, S.; Golper, T. Drug-induced acute kidney injury. Curr. Opin. Crit. Care 2005, 11, 555-565
143. Jenkinson, S.E.; Chung, G.W.; van Loon, E.; Bakar, N.S.; Dalzell, A.M.; Brown, C.D.A. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch. Eur. J. Physiol. 2012, 464, 601-611
144. Snouber, L.C.; Letourneur, F.; Chafey, P.; Broussard, C.; Monge, M.; Legallais, C.; Leclerc, E. Analysis of transcriptomic and proteomic profiles demonstrates improved Madin-Darby canine kidney cell function in a renal microfluidic biochip. Biotechnol. Prog. 2012, 28, 474-484
145. Essig, M.; Terzi, F.; Burtin, M.; Friedlander, G. Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells. Am. J. Physiol. Ren. Physiol. 2001, 281, F751-F762
146. Bhat, V.D.; Windridge, P.A.; Cherry, R.S.; Mandel, L.J. Fluctuating shear stress effects on stress fiber architecture and energy metabolism of cultured renal cells. Biotechnol. Prog. 1995, 11, 596-600
147. Du, Z.; Yan, Q.; Duan, Y.; Weinbaum, S.; Weinstein, A.M.; Wang, T. Axial flow modulates proximal tubule NHE3 and H-ATPase activities by changing microvillus bending moments. Am. J. Physiol. Ren. Physiol. 2006, 290, F289-F296
148. Wilmer, M.J.; Ng, C.P.; Lanz, H.L.; Vulto, P.; Suter-Dick, L.; Masereeuw, R. Kidney-on-a-chip technology for drug-induced nephrotoxicity screening. Trends Biotechnol. 2016, 34, 156-170
149. Leclerc, E.; Sakai, Y.; Fujii, T. Microfluidic PDMS (Polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes. Biotechnol. Prog. 2004, 20, 750-755
150. Baudoin, R.; Griscom, L.; Monge, M.; Legallais, C.; Leclerc, E. Development of a renal microchip for in vitro distal tubule models. Biotechnol. Prog. 2007, 23, 1245-1253
151. Schneider, M.; Marison, I.W.; von Stockar, U. The importance of ammonia in mammalian cell culture. J. Biotechnol. 1996, 46, 161-185
152. Choucha Snouber, L.; Jacques, S.; Monge, M.; Legallais, C.; Leclerc, E. Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochips. Genomics 2012, 100, 27-34
153. Karin, M. The IkappaB kinase-A bridge between inflammation and cancer. Cell Res. 2008, 18, 334-342
154. Elwi, A.N.; Damaraju, V.L.; Kuzma, M.L.; Mowles, D.A.; Baldwin, S.A.; Young, J.D.; Sawyer, M.B.; Cass, C.E. ransepithelial fluxes of adenosine and 20-deoxyadenosine across human renal proximal tubule cells: Roles of nucleoside transporters hENT1, hENT2, and hCNT. Am. J. Physiol. Ren. Physiol. 2009, 296, F1439-F1451
155. Rebelo, L.; Carmo-Fonseca, M.; Moura, T.F. Redistribution of microvilli and membrane enzymes in isolated rat proximal tubule cells. Biol. Cell 1992, 74, 203-209
156. Jang, K.-J.; Cho, H.S.; Kang, D.H.; Bae, W.G.; Kwon, T.-H.; Suh, K.-Y. Fluid-shear-stress-induced translocation of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells. Integr. Biol. 2011, 3, 134-141
157. Ramello, C.; Paullier, P.; Ould-Dris, A.; Monge, M.; Legallais, C.; Leclerc, E. Investigation into modification of mass transfer kinetics by acrolein in a renal biochip. Toxicol. In Vitro 2011, 25, 1123-1131
158. Kim, S.; LesherPerez, S.C.; Kim, B.C.C.; Yamanishi, C.; Labuz, J.M.; Leung, B.; Takayama, S. Pharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip. Biofabrication 2016, 8, 015021
159. Mavros, M.N.; Polyzos, K.A.; Rafailidis, P.I.; Falagas, M.E. Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: A systematic review and meta-analysis. J. Antimicrob. Chemother. 2011, 66, 251-259
160. Duan, Y.; Gotoh, N.; Yan, Q.; Du, Z.; Weinstein, A.M.; Wang, T.; Weinbaum, S. Shear-induced reorganization of renal proximal tubule cell actin cytoskeleton and apical junctional complexes. Proc. Natl. Acad. Sci. USA 2008, 105, 11418-11423
161. Andes, D.; Craig, W.A. Animal model pharmacokinetics and pharmacodynamics: A critical review. Int. J. Antimicrob. Agents 2002, 19, 261-268
162. Paine, S.W.; Ménochet, K.; Denton, R.; McGinnity, D.F.; Riley, R.J. Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption. Drug Metab. Dispos. 2011, 39, 1008-1013
163. Chu, X.; Bleasby, K.; Evers, R. Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin. Drug Metab. Toxicol. 2012, 5255, 1-16
164. Pfaller, W.; Gstraunthaler, G. Nephrotoxicity testing in vitro-What we know and what we need to know. Environ. Health Perspect. 1998, 106 (Suppl. 2), 559-569
165. Jang, K.-J.; Mehr, A.P.; Hamilton, G.A.; McPartlin, L.A.; Chung, S.; Suh, K.-Y.; Ingber, D.E. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. (Camb.) 2013, 5, 1119-1129
166. Adler, M.; Ramm, S.; Hafner, M.; Muhlich, J.L.; Gottwald, E.M.; Weber, E.; Jaklic, A.; Ajay, A.K.; Svoboda, D.; Auerbach, S.; et al. A quantitative approach to screen for nephrotoxic compounds in vitro. J. Am. Soc. Nephrol. 2016, 27, 1015-1028
167. Kelly, E.J.; Wang, Z.; Voellinger, J.L.; Yeung, C.K.; Shen, D.D.; Thummel, K.E.; Zheng, Y.; Ligresti, G.; Eaton, D.L.; Muczynski, K.A.; et al. Innovations in preclinical biology: Ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res. Ther. 2013, 4 (Suppl. 1), S17
168. Weber, E.J.; Chapron, A.; Chapron, B.D.; Voellinger, J.L.; Lidberg, K.A.; Yeung, C.K.; Wang, Z.; Yamaura, Y.; Hailey, D.W.; Neumann, T.; et al. Development of a microphysiological model of human kidney proximal tubule function. Kidney Int. 2016, 90, 627-637
169. Madden, L.; Juhas, M.; Kraus, W.E.; Truskey, G.A.; Bursac, N. Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. eLife 2015, 4, e04885
170. Occhetta, P.; Centola, M.; Tonnarelli, B.; Redaelli, A.; Martin, I.; Rasponi, M. High-throughput microfluidic platform for 3D cultures of mesenchymal stem cells, towards engineering developmental processes. Sci. Rep. 2015, 5, 10288
171. Dodson, K.H.; Echevarria, F.D.; Li, D.; Sappington, R.M.; Edd, J.F. Retina-on-a-chip: A microfluidic platform for point access signaling studies. Biomed. Microdevices 2015, 17, 1-10
172. Rigat-Brugarolas, L.G.; Elizalde-Torrent, A.; Bernabeu, M.; de Niz, M.; Martin-Jaular, L.; Fernandez-Becerra, C.; Homs-Corbera, A.; Samitier, J.; del Portillo, H.A. A functional microengineered model of the human splenon-on-a-chip. Lab Chip 2014, 14, 1715-1724
173. Clavica, F.; Homsy, A.; Jeandupeux, L.; Obrist, D. Red blood cell phase separation in symmetric and asymmetric microchannel networks: Effect of capillary dilation and inflow velocity. Sci. Rep. 2016, 6, 36763
174. Nguyen, T.Q.; Park, W.T. Rapid, low-cost fabrication of circular microchannels by air expansion into partially cured polymer. Sens. Actuators B Chem. 2016, 235, 302-308
175. Maschmeyer, I.; Lorenz, A.K.; Schimek, K.; Hasenberg, T.; Ramme, A.P.; Hübner, J.; Lindner, M.; Drewell, C.; Bauer, S.; Thomas, A.; et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 2015, 15, 2688-2699
176. Materne, E.M.; Ramme, A.P.; Terrasso, A.P.; Serra, M.; Alves, P.M.; Brito, C.; Sakharov, D.A.; Tonevitsky, A.G.; Lauster, R.; Marx, U. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. J. Biotechnol. 2014, 205, 36-46
177. Vunjak-Novakovic, G.; Bhatia, S.; Chen, C.; Hirschi, K. HeLiVa platform: Integrated heart-liver-vascular systems for drug testing in human health and disease. Stem Cell Res. Ther. 2013, 4, 1-6
178. Van Midwoud, P.M.; Merema, M.T.; Verpoorte, E.; Groothuis, G.M.M. A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab Chip 2010, 10, 2778-2786
179. Wagner, I.; Materne, E.-M.; Brincker, S.; Süssbier, U.; Frädrich, C.; Busek, M.; Sonntag, F.; Sakharov, D.A.; Trushkin, E.V.; Tonevitsky, A.G.; et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 2013, 13, 3538-3547
180. Marx, U.; Walles, H.; Hoffmann, S.; Lindner, G.; Horland, R.; Sonntag, F.; Klotzbach, U.; Sakharov, D.; Tonevitsky, A.; Lauster, R. "Human-on-a-chip" developments: A translational cuttingedge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? ATLA Altern. Lab. Anim. 2012, 40, 235-257
181. Sung, J.H.; Esch, M.B.; Prot, J.-M.; Long, C.J.; Smith, A.; Hickman, J.J.; Shuler, M.L. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip 2013, 13, 1201-1212
182. Sung, J.H.; Kam, C.; Shuler, M.L. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 2010, 10, 446-455
183. Wikswo, J.P.; Curtis, E.L.; Eagleton, Z.E.; Evans, B.C.; Kole, A.; Hofmeister, L.H.; Matloff, W.J. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip 2013, 13, 3496-3511
184. Moraes, C.; Labuz, J.M.; Leung, B.M.; Inoue, M.; Chun, T.-H.; Takayama, S. On being the right size: Scaling effects in designing a human-on-a-chip. Integr. Biol. 2013, 5, 1149-1161
185. Viravaidya, K.; Sin, A.; Shuler, M.L. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog. 2004, 20, 316-323
186. Abaci, H.E.; Shuler, M.L. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. Integr. Biol. 2015, 7, 383-391